Prevention and Treatment of Complications of Endovascular Methods in Patients With Malignant Liver Tumors

Exclusion Criteria

• •1. Metachronous (within 3 years) or synchronous other oncological disease with the exception of healed carcinoma in situ;
• •2. The volume of liver damage according to computed tomography is more than 60%;
• •3. Increase in the level of transaminases by more than 2 times;
• •4. The level of bilirubin is more than 50 μmol / l;
• •5. Heart failure stage II B-III, Functional Class III-IV;
• •6. The presence of uncorrected coagulopathy;
• •7. Renal failure stage III-IV;
• •8. Ascites 2-3 degrees;
• •9. The general condition of the patient is below 60% on the Karnofsky index and above 2 points on the Eastern Cooperative Oncology Group (ECOG) scale;
• •10. Liver damage - more than 7 points on the Child-Pugh scale;
• •11. Damage to the central nervous system;
• •12. Anemia of severe severity;
• •13. Pregnancy;
• •14. Active autoimmune disease;
• •15. Presence of HIV infection, active forms of tuberculosis;